Main > ONCOLOGY (**) > MyeloDysplastic Syndromes>Anemia > TREAT.: > USA. B. Luspatercept-Aamt for Inj.

---

USA. B. Luspatercept-Aamt for Inj.'s subsections
(*) EU Approval Date: 2020. 06.26
(*) USA Approval Date: 2020. 04.03.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2020. 09.15.
TradeMark
TradeMark Web-Site

USA. B. Luspatercept-Aamt for Inj.'s products
This section has no products